Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ¾à¹°Àü´Þ > U.S. Ocular Drug Delivery Market
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

U.S. Ocular Drug Delivery Market

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2008³â 10¿ù »óǰÄÚµå 76104
ÆäÀÌÁö Á¤º¸ 61 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This research service explores the market for drug delivery used for the treatment of ocular diseases in the Unites States of America. It analyzes the various challenges faced by pharmaceutical, biotech, and drug delivery companies, and the competitive advantages and disadvantages of their products in the market.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • Overview

2. MARKET INTRODUCTION

Research Scope and Methodology

  • Scope and Segmentation
  • Methodology

Market Overview

  • Market Engineering Measurements
  • Technology Overview
  • Disease Targets and Applications
  • Challenges and Strategies
  • Market Drivers

3. COMPETITIVE ANALYSIS

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis

Forecasts and Trends

  • Revenue Forecast
  • Technology Analysis - Topical Applications
  • Technology Analysis - Ocular Injections
  • Technology Analysis - Ocular Implants

4. APPENDIX

Decision Support Databases

  • New Cases of Age Related Macular Degeneration
  • Age Related Macular Degeneration Prevalence
  • Total Population
  • New Cases of Glaucoma
  • Prevalence of Glaucoma
  • New Cases of Diabetes
  • Prevalence of Diabetes
Back to Top